- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04526158
Learning to Apply Mindfulness to Pain (LAMP)
April 10, 2023 updated by: Diana J. Burgess, United States Department of Defense
Testing Two Scalable, Veteran-centric Mindfulness-based Interventions for Chronic Musculoskeletal Pain: A Pragmatic, Multisite Trial
The long-term goal of this two-phase project is to reduce chronic pain and co-morbid conditions among Veterans, through scalable, non-pharmacologic evidence-based strategies that are "Veteran-Centric," designed to optimize engagement, adherence and sustainability, and are deliverable to large numbers of Veterans.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
The investigators will conduct a 3-site 3-arm pragmatic clinical trial (N = 750) to test effectiveness of 2 Mindfulness-Based Interventions (MBIs), Mobile+Group LAMP and Mobile LAMP, compared to usual practice.
Effectiveness will be assessed by pain functioning over the 12-month follow-up period using the Brief Pain Inventory (BPI) interference score.
The investigators will test the following primary hypotheses: (1) Mobile LAMP will be more effective at improving chronic pain (as measured by change in the BPI interference score over the 12-month follow-up period) compared to usual practice, (2) Mobile+Group LAMP will be more effective at improving chronic pain (as measured by BPI interference score over the 12-month follow-up period) compared to usual practice, and (3) Mobile+Group LAMP will be more effective at improving chronic pain (as measured by BPI interference change over the 12-month follow-up period) compared to Mobile LAMP without the group component.
The investigators will test the following secondary hypotheses: (1) Comparison of intervention group with secondary outcomes listed below, and (2) primary and secondary hypotheses comparisons will be confirmed in gender-specific strata.
The primary outcome will be measured as change in BPI interference score over the 12-month follow-up period.
Secondary outcomes will include patient-reported measures related to pain, comorbid mental health conditions and function, expected mediators of treatment effects, patient satisfaction, and adverse effects and measures captured in electronic health records.
These outcomes will be assessed at 10 weeks, 6 months and 12 months.
Implementation data will be collected and described, using the guided Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.
Study Type
Interventional
Enrollment (Actual)
811
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55417
- Minnesota Veteran Administration Health Care System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Must have qualifying pain diagnoses on at least 2 occasions, at least 90 days apart, within the same pain category, during the previous 2 years
- Must report having a pain duration of ≥ 6 months (pain chronicity threshold), and a pain severity score of ≥ 4 on the 0-10 Numeric Rating Scale (pain severity threshold).
- Must have access to a smart phone that meets the requirement of the mobile app software
- Must be willing and able to download the mobile app on their phone
- Must have wireless or cellular internet access on a daily basis
- Must be willing to meet via video conference on the dates and at the time when Mobile+Group LAMP sessions are held, and attend all sessions of the arm to which they are randomized.
Exclusion Criteria:
- new diagnosis of schizophrenia, bipolar disorder, major depressive disorder, or other psychosis within the past 18 months; or current active psychotic symptoms, suicidality, severe depression, manic episode, and/or poorly controlled bipolar disorder (as assessed by a medical chart review)
- currently enrolled in a research study for pain
- currently enrolled in mindfulness-based stress reduction (MBSR)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mobile+Group LAMP Mindfulness-Based Intervention
8 weekly, synchronous interactive online group sessions; access to mobile app and a study website, with an accompanying workbook.
|
The Mobile+Group LAMP Mindfulness-Based Intervention (MBI) condition consists of eight 90-minute weekly group sessions, delivered via secure video-conferencing.
The first session is preceded by a 90-minute technical session introducing the video-conference system and other logistics.
The program consists of educational and instructional videos presented by a trained mindfulness instructor interspersed with workbook reflections and group discussions, and daily practice exercises that participants do on their own.
A trained facilitator (who is not required to be an expert in mindfulness) leads the group.
Participants also have access to a mobile app and a study website, with the same educational and instructional videos that are presented in the group sessions, and the accompanying workbook.
Other Names:
|
Experimental: Mobile LAMP Mindfulness-Based Intervention
8 weekly asynchronous sessions, delivered on mobile app and study website, with an accompanying workbook; 3 engagement calls at the middle, beginning and end of the program.
|
The Mobile LAMP MBI consists of 8 self-paced, 30- to 60-minute weekly sessions, delivered on a mobile app and available on the study website, with an accompanying workbook.
The program consists of educational and instructional videos presented by a trained mindfulness instructor, with workbook reflections and daily practice exercises that participants do on their own (the same content used in Mobile+Group LAMP).
Participants also participate in 3 engagement phone calls with a facilitator.
The 1st call (45-60 minutes), held at the beginning of the program, includes technical and logistical information on engaging with mobile app, website, and workbook; and discussion of goals, challenges and plans for practice.
The 2nd (middle of program) and 3rd call (end of program) are 25-45 minutes long and address technical/logistical issues and discussion of goals, progress, plans for practice and strategies to address challenges.
Other Names:
|
No Intervention: Usual Care
Engagement in usual care for 12 months as participants normally would.
After the entire follow-up period is complete (12 months), participants in the usual care arm are given access to the Mobile LAMP materials MBI training on the app and study website, and the accompanying workbook.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Brief Pain Inventory (BPI) interference score from baseline, over the 12-month follow-up period.
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months, to capture short-term, mid-term, and long-term effects
|
Minimum value: 0. Maximum value: 10.
Higher scores indicate worse functioning.
|
Assessed at baseline, 10 weeks, 6 months, and 12 months, to capture short-term, mid-term, and long-term effects
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Brief Pain Inventory (BPI) intensity score from baseline, over the 12-month follow-up period.
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months, to capture short-term, mid-term, and long-term effects
|
Minimum value: 0. Maximum value: 10.
Higher scores indicate more severe pain.
|
Assessed at baseline, 10 weeks, 6 months, and 12 months, to capture short-term, mid-term, and long-term effects
|
Change in anxiety over the 12-month follow-up period assessed by mean score on the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile v.2.0 measure of anxiety
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 1. Maximum value: 5. Higher scores indicate worse anxiety
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Change in fatigue over the 12-month follow-up period assessed by mean score on the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile v.2.0 measure of fatigue
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 1. Maximum value:5.
Higher scores indicate worse fatigue
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Change in depression over the 12-month follow-up period assessed by score on the eight-item Patient Health Questionnaire depression scale (PHQ8)
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 0. Maximum value: 24.
Higher scores indicate greater depression
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Change in Post Traumatic Stress Disorder (PTSD), over the 12-month follow-up period, assessed by participants' scores on the Post Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders - 5 (PCL-5)
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 0. Maximum value: 80. Higher scores indicate greater PTSD
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Mean global improvement of pain score, over the 12-month follow-up period
Time Frame: Assessed at 10 weeks, 6 months, and 12 months
|
Global impression of change scale from "much better" to "much worse"
|
Assessed at 10 weeks, 6 months, and 12 months
|
Change in physical functioning over the 12-month follow-up period assessed by mean score on the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile v.2.0 measure of physical function
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 1. Maximum value: 5. Lower scores indicate worse physical functioning
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Change in sleep disturbance over the 12-month follow-up period assessed by mean score on the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile v.2.0 measure of sleep disturbance
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 1. Maximum value: 5. Higher scores indicate worse sleep disturbance
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Change in participation in social roles and activities over the 12-month follow-up period assessed by mean score on the PROMIS-29 Profile v.2.0 measure of participation in social roles and activities
Time Frame: Assessed at baseline, 10 weeks, 6 months, and 12 months
|
Minimum value: 1. Maximum value: 5. Lower scores indicate greater participation in social roles and activities
|
Assessed at baseline, 10 weeks, 6 months, and 12 months
|
BPI Interference Score Responder Analysis
Time Frame: Assessed at 10 weeks, 6 months, and 12 months.
|
Change in Brief Pain Inventory (BPI) interference score over the 12-month follow-up period.
Number with 30% improvement in BPI inference score to capture short-term, mid-term, and long-term effects.
|
Assessed at 10 weeks, 6 months, and 12 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2020
Primary Completion (Anticipated)
December 30, 2023
Study Completion (Anticipated)
December 30, 2023
Study Registration Dates
First Submitted
July 9, 2020
First Submitted That Met QC Criteria
August 21, 2020
First Posted (Actual)
August 25, 2020
Study Record Updates
Last Update Posted (Actual)
April 12, 2023
Last Update Submitted That Met QC Criteria
April 10, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- #NH170001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Istanbul UniversityCompletedLow Back Pain, Mechanical, Biofeedback, Pain, Chronic
-
Vastra Gotaland RegionActive, not recruitingPain, Chronic | Widespread Chronic PainSweden
Clinical Trials on Mobile+Group LAMP Mindfulness-Based Intervention
-
The University of Hong KongActive, not recruitingPsychological Distress | Mental Health Wellness 1Hong Kong
-
Oslo Metropolitan UniversityRecruiting
-
City, University of LondonCompletedStress | AnxietyUnited Kingdom
-
Duke UniversityUniversity of Colorado, Denver; University of Washington; National Center for...CompletedCardiorespiratory FailureUnited States
-
Universiti Putra MalaysiaRecruitingMental Health Issue | Smartphone AddictionChina
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong Kong; Jilin Medical College, China; Taipei Medical University...CompletedSchizophreniaHong Kong, China, Taiwan
-
University of PittsburghNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedSexual Dysfunction | Female Sexual Dysfunction | Hypoactive Sexual Desire DisorderUnited States
-
Hopital MontfortUniversity of Ottawa; Ontario Mental Health FoundationCompletedSocial Anxiety DisorderCanada
-
Yu-Chien HuangCompletedCOVID-19 | Mental Health | Nurse | Cell Phone UseTaiwan
-
Singapore General HospitalCompletedDepression | Stroke | Stress | AnxietySingapore